Cherian Sarah, Burgner David P, Carson Christine F, Sanfilippo Frank M, Cook Angus G, Forbes David A
School of Paediatrics and Child Health, University of Western Australia, Princess Margaret Hospital for Children, Perth, WA, Australia.
J Pediatr Gastroenterol Nutr. 2008 Aug;47(2):130-5. doi: 10.1097/MPG.0b013e31815bc5b3.
Accurate methods for diagnosing active Helicobacter pylori infection in children have been limited to invasive or time-consuming techniques. Recently, fecal antigen testing has been used successfully for the diagnosis of H pylori infection in the pediatric population. We compared 2 monoclonal fecal antigen diagnostic methods in a population of children with a suspected high prevalence of H pylori infection. We also assessed the diagnostic performance of H pylori immunoglobulin G serology.
In a cross-sectional study of African refugee children (<16 years) we compared an immunochromatographic technique (ICT) and serology with a monoclonal fecal antigen enzyme immunoassay (MFAT) method for the detection of active H pylori infection. Following the manufacturer's instructions, an optical density of >or=0.190 was used as a cutoff for MFAT. Sensitivity, specificity, and positive and negative predictive values were calculated.
Of the 193 eligible children enrolled, active H pylori infection was detected in 149 of 182 (81.9%) in whom MFAT was performed. The prevalence of active infection increased with age; children with active infection were significantly older, and there were no sex differences. ICT and serology underperformed in comparison with MFAT (ICT sensitivity 74.6%, specificity 63.6%, positive predictive value 89.8%, negative predictive value 36.8%; and serology sensitivity 57.9%, specificity 77.4%, positive predictive value 92.0%, negative predictive value 29.9%).
Monoclonal enzyme immunoassay fecal antigen testing is a practical and feasible alternative to traditional invasive diagnostic methods in high-prevalence pediatric populations. Neither immunochromatography nor serology is useful for the diagnosis of active H pylori infection in these children.
诊断儿童幽门螺杆菌现症感染的准确方法一直局限于侵入性或耗时的技术。近来,粪便抗原检测已成功用于儿科人群幽门螺杆菌感染的诊断。我们在疑似幽门螺杆菌感染患病率较高的儿童人群中比较了两种单克隆粪便抗原诊断方法。我们还评估了幽门螺杆菌免疫球蛋白G血清学的诊断性能。
在一项针对非洲难民儿童(<16岁)的横断面研究中,我们将免疫层析技术(ICT)和血清学与单克隆粪便抗原酶免疫测定(MFAT)方法进行比较,以检测幽门螺杆菌现症感染。按照制造商的说明,将MFAT的光密度≥0.190用作临界值。计算敏感性、特异性以及阳性和阴性预测值。
在纳入的193名符合条件的儿童中,182名进行了MFAT检测,其中149名(81.9%)检测到幽门螺杆菌现症感染。现症感染的患病率随年龄增加;现症感染儿童的年龄显著更大,且无性别差异。与MFAT相比,ICT和血清学表现欠佳(ICT敏感性74.6%,特异性63.6%,阳性预测值89.8%,阴性预测值36.8%;血清学敏感性57.9%,特异性77.4%,阳性预测值92.0%,阴性预测值29.9%)。
在高患病率的儿科人群中,单克隆酶免疫测定粪便抗原检测是传统侵入性诊断方法的一种实用可行的替代方法。免疫层析和血清学均无助于诊断这些儿童的幽门螺杆菌现症感染。